
AU  - Ritchey, Mary Elizabeth
AU  - West, Suzanne L.
AU  - Maldonado, George
C7  - pp. 948-990
TI  - Validity of Drug and Diagnosis Data in Pharmacoepidemiology
SN  - 9781119413417
UR  - https://doi.org/10.1002/9781119413431.ch37
DO  - doi:10.1002/9781119413431.ch37
SP  - 948-990
KW  - accuracy
KW  - databases
KW  - measurement error
KW  - questionnaires
KW  - reliability
KW  - validity
PY  - 2019
AB  - Summary Accurate pharmacoepidemiologic study conclusions require assessment of valid data, regardless of whether the data originate from questionnaires, administrative claims, or electronic health records. This chapter provides an overview of current methodologic concerns in validation studies, including types and detection of measurement error, effects of error on the point estimate of association, and correction options. Validity issues for diagnosis and medication data, and how the accuracy of these data varies by patient and other characteristics, are also discussed. Two examples are provided to illustrate validation efforts for questionnaires and electronic data: nonsteroidal antiinflammatory drugs (NSAIDs) and myocardial infarction and NSAIDs and gastrointestinal bleeding. Current solutions include steps to consider when designing and analyzing validation studies using either questionnaire or electronic data. The chapter concludes with a discussion of the continued need for validation studies, especially as research moves toward incorporation of new data sources, increase in data linkage, and use of unstructured data for pharmacoepidemiology research.
ER  - 

C7  - pp. 537-552
TI  - Index
SN  - 9780813810461
UR  - https://doi.org/10.1002/9781118704769.index
DO  - doi:10.1002/9781118704769.index
SP  - 537-552
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 217
IS  - S708
SN  - 9780813810461
UR  - https://doi.org/10.1111/apha.12712
DO  - doi:10.1111/apha.12712
SP  - 3
EP  - 158
PY  - 2016
ER  - 

TY  - JOUR
TI  - PAPERS BY AUTHOR
JO  - Annals of the New York Academy of Sciences
JA  - Annals of the New York Academy of Sciences
VL  - 711
IS  - 1
SN  - 9780813810461
UR  - https://doi.org/10.1111/j.1749-6632.1994.tb00015.x
DO  - doi:10.1111/j.1749-6632.1994.tb00015.x
SP  - 7
EP  - 200
PY  - 1994
ER  - 

TY  - JOUR
AU  - Szczepiorkowski, Zbigniew M.
AU  - Winters, Jeffrey L.
AU  - Bandarenko, Nicholas
AU  - Kim, Haewon C.
AU  - Linenberger, Michael L.
AU  - Marques, Marisa B.
AU  - Sarode, Ravindra
AU  - Schwartz, Joseph
AU  - Weinstein, Robert
AU  - Shaz, Beth H.
TI  - Guidelines on the use of therapeutic apheresis in clinical practiceâ€”Evidence-based approach from the apheresis applications committee of the American Society for Apheresis
JO  - Journal of Clinical Apheresis
JA  - J. Clin. Apheresis
VL  - 25
IS  - 3
SN  - 9780813810461
UR  - https://doi.org/10.1002/jca.20240
DO  - doi:10.1002/jca.20240
SP  - 83
EP  - 177
KW  - apheresis
KW  - plasma exchange
KW  - immunoadsorption
KW  - leukocytapheresis
KW  - photopheresis
KW  - categories
KW  - indications
KW  - evidence based
PY  - 2010
AB  - Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged with a review and categorization of indications for therapeutic apheresis. Beginning with the 2007 ASFA Special Issue (fourth edition), the subcommittee has incorporated systematic review and evidence-based approach in the grading and categorization of indications. This Fifth ASFA Special Issue has further improved the process of using evidence-based medicine in the recommendations by refining the category definitions and by adding a grade of recommendation based on widely accepted GRADE system. The concept of a fact sheet was introduced in the Fourth edition and is only slightly modified in this current edition. The fact sheet succinctly summarizes the evidence for the use of therapeutic apheresis. The article consists of 59 fact sheets devoted to each disease entity currently categorized by the ASFA as category I through III. Category IV indications are also listed. J. Clin. Apheresis, 2010. ? 2010 American Society for Apheresis
ER  - 

TY  - JOUR
TI  - Invited Speakers
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 48
IS  - S1
SN  - 9780813810461
UR  - https://doi.org/10.1111/eci.12924
DO  - doi:10.1111/eci.12924
SP  - 15
EP  - 43
PY  - 2018
ER  - 

TY  - JOUR
AU  - Chapin, Robert E.
AU  - Adams, Jane
AU  - Boekelheide, Kim
AU  - Gray Jr, L. Earl
AU  - Hayward, Simon W.
AU  - Lees, Peter S.J.
AU  - McIntyre, Barry S.
AU  - Portier, Kenneth M.
AU  - Schnorr, Teresa M.
AU  - Selevan, Sherry G.
AU  - Vandenbergh, John G.
AU  - Woskie, Susan R.
TI  - NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A
JO  - Birth Defects Research Part B: Developmental and Reproductive Toxicology
JA  - Birth Defects Research Part B: Developmental and Reproductive Toxicology
VL  - 83
IS  - 3
SN  - 9780813810461
UR  - https://doi.org/10.1002/bdrb.20147
DO  - doi:10.1002/bdrb.20147
SP  - 157
EP  - 395
PY  - 2008
ER  - 
